TP53 and breast cancer: It has been shown to restore DNA binding capacity of mutant p53, thereby inducing activation of p53 target genes including p21, PUMA, and NOXA. In vitro data revealed that breast cancer cell lines harboring mutant p53 exhibit significantly lower IC50 than those with wild-type p53 107.